中性粒细胞与淋巴细胞比值及鳞状细胞癌抗原预测宫颈鳞状细胞癌患者预后价值分析

宫颈癌是全世界第二大常见妇科恶性肿瘤,每年约50万新诊断病例和27.5万死亡病例,近三分之一的宫颈癌患者死于疾病复发或疾病进展,其中鳞状细胞癌是宫颈癌最常见的细胞类型,其治疗方式有手术、放化疗等.目前宫颈鳞状细胞癌的预后评价常根据术后病理指标,多项研究表明治疗前外周血中性粒细胞与淋巴细胞比值(NLR)对经过放射治疗的宫...

The Prognostic Value of the Ratio of Neutrophils to Lymphocytes and Squamous Cell Carcinoma Antigen in Patients with Cervical Squamous Cell Carcinoma

Cervical cancer is the second most common gynecological malignancy in the world,causing about 500000 new diagnoses and 275000 deaths each year.Nearly one-third of cervical cancer deaths are due to disease recurrence or progression.Squamous cell carcinoma is the most common type of cervical cancer.The treatment of squamous cell cervical cancer includes surgery,chemoradiotherapy and so on.And most of the known prognostic factors of squamous cell cervical cancer are evaluated after operation.Survival studies showed that the ratio of neutrophils to lymphocytes(NLR)in peripheral blood before treatment had a significant influence on the prognosis of patients with squamous cell cervical cancer after radiotherapy.And the serum squamous cell carcinoma antigen(SCC-Ag)level had a predictive effect on the recurrence,survival and lymph node metastasis of patients with squamous cell cervical cancer.NLR and SCC-Ag in peripheral blood can be easily obtained as hematological indexes.Compared with the local state of cancer reflected by International Federation of Gynecology and Obstetrics(FIGO)stage,they can better reflect the general state of patients.Also,they can be dynamically monitored from the beginning of diagnosis,which becomes reference factors for clinicians to provide the best diagnosis and treatment for patients.By elucidating the predictive value of NLR and SCC-Ag in the prognosis of cervical squamous cell carcinoma,it is expected to create a new way to analysis the progression of cervical squamous cell carcinoma.